Crescent Biopharma (CBIO) Operating Leases (2019 - 2026)
Crescent Biopharma (CBIO) posted quarterly Operating Leases of $1.4 million for Q2 2026, down 12.59% year-over-year from $1.6 million in Q2 2025, and down 6.87% quarter-over-quarter from $1.5 million in Q1 2026.
Crescent Biopharma (CBIO) Operating Leases (2019 - 2026) Analysis & Trends
Crescent Biopharma (CBIO) has reported Operating Leases for 7 consecutive years, with $1.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Leases fell 12.59% year-over-year to $1.4 million; the TTM figure through Jun 2026 stood at $1.4 million (down 12.59% YoY), while the FY2025 annual figure was $1.2 million, changed N/A from the prior year.
- Operating Leases fell to $1.4 million in Q2 2026 per CBIO's latest filing, from $1.5 million in the prior quarter.
- Across five years, Operating Leases topped out at $1.7 million in Q3 2025 and bottomed at $66844.0 in Q4 2023.
- Historically, Operating Leases has averaged $861631.2 across 4 years, with a median of $651786.0 in 2022.
- Annual changes were most pronounced in 2022 — Operating Leases tumbled 91.9% — and 2023, when it surged 174.16%.
- Crescent Biopharma's Operating Leases stood at $95613.0 in 2022, then sank by 30.09% to $66844.0 in 2023, then surged by 1708.69% to $1.2 million in 2025, then advanced by 18.86% to $1.4 million in 2026.
- Business Quant data shows CBIO's Operating Leases at $1.4 million in Q2 2026, $1.5 million in Q1 2026, and $1.2 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Crescent Biopharma | 1.05 Bn | 875.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.44 Mn |
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Dec 31, 2023 | 66,844.00 |
| Sep 30, 2023 | 262,133.00 |
| Jun 30, 2023 | 448,775.00 |
| Sep 30, 2022 | 95,613.00 |
| Jun 30, 2022 | 378,792.00 |
| Mar 31, 2022 | 651,786.00 |
| Dec 31, 2021 | 918,607.00 |
| Sep 30, 2021 | 1.18 Mn |
| Jun 30, 2021 | 1.44 Mn |
| Mar 31, 2021 | 1.68 Mn |
| Dec 31, 2020 | 1.92 Mn |
| Sep 30, 2020 | 2.15 Mn |
| Jun 30, 2020 | 2.38 Mn |
| Mar 31, 2020 | 2.60 Mn |
| Dec 31, 2019 | 2.82 Mn |